Antimicrobial prophylaxis in oral surgery and dental procedures;Profilaxis antimicrobiana en cirugía oral y procedimientos odontológicos

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 12, Issue 1, 2007, Pages 32-41

  Maestre Vera, Juan Ramón ^a   Gómez Lus Centelles, María Luisa ^b  

^a UNIVERSIDAD ALFONSO X EL SABIO   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Amoxicillin clavulanic acid; Dental procedures; Oral surgery; Prophylaxis

Indexed keywords

AMOXICILLIN; BETA LACTAMASE; CLAVULANIC ACID; CLINDAMYCIN; MACROLIDE; METRONIDAZOLE; PENICILLIN G;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTERIOSCLEROSIS; ARTICLE; BACTEREMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; DENTAL SURGERY; DISEASE COURSE; DISEASE PREDISPOSITION; HEART VALVE PROSTHESIS; HUMAN; IMMUNE RESPONSE; INFECTION COMPLICATION; JOINT PROSTHESIS; ORAL SURGERY; PERIODONTITIS; RISK FACTOR;

EID: 33846551901     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. a Edición. Madrid: McGraw-Hill Interamericana Editores; 2002. p. 515-25.
2. Okell CC, Elliott D. Bacteremia and oral sepsis with special reference to aetiology of bacterial endocarditis. Lancet 1935;2:869-72.
3. Fine DH, Hammond BF, Loesche WJ. Clinical use of antibiotics in dental practice. Int J Antimicrob Agents 1998;9:235-8.
4. Tomás Carmona I, Diz Dios P, Scully C. An update on the controversies in bacterial endocarditis of oral origin. Oral Surg Oral Med Oral Pathol 2002;93:660-70.
5. Berbari EF, Cockerill FR 3rd, Steckelberg JM. Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc 1997;72:532-42.
6. Okabe K, Nakagawa K, Yamamoto E. Factors affecting the occurrence of bacteremia associated with tooth extraction. Int J Oral Maxillofac Surg 1995;24:239-42.
7. Rajasuo A, Perkki K, Nyfors S, Jousimies-Somer H, Meurman JH. Bacteremia following surgical dental extraction with an emphasis on anaerobic strains. J Dent Res 2004;83:170-4.
8. Otten JE, Pelz K, Christmann G. Anaerobic bacteremia following tooth extraction and removal of osteosynthesis plates. J Oral Maxillofac Surg 1987;45:477-80.
9. Lockhart PB, Brennan MT, Kent ML, Norton HJ, Weinrib DA. Impact of amoxicillin prophylaxis on the incidence, nature, and duration of bacteremia in children after intubation and dental procedures. Circulation 2004;109:2878-84.
10. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR, Sacco RL, et al. Periodontal microbiota and carotid intima-media thickness: the oral infections and vascular disease epidemiology study (INVEST). Circulation 2005;111:576-82.
11. Demmer RT, Desvarieux M. Periodontal infections and cardiovascular disease. J Am Dent Assoc 2006;137:S14-20.
12. Gutiérrez JL, Bagan JV, Bascones A. Documento de consenso sobre la utilización de profilaxis antibiótica en cirugía y procedimientos dentales. Med Oral Patol Oral Cir Bucal 2006;11:E188-205.
13. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodonlal pathogens in atheromatous plaques. J Periodontol 2000;71:1554-60.
14. Chiu B. Multiple infections in carotic atherosclerosis plaques. Am Heart J 1999;138:S534-6.
15. Herzberg MC, Meyer MW. Effects of oral flora on platelets: possible consequences in cardiovascular disease. J Periodontol 1996; 67, suppl 10: 1138-42.
16. Mahanonda R, Sa-Ard-Ian N, Charatkulangkun O. Monocyte activation by Porphyromonas gingivalis LPS in aggressive with the use of whole-blood cultures. J Dent Res 2004;83:540-5.
17. Song H, Bélager M, Whitlock J, Kozarov E, Progulske-Fox A. Hemagglutinin B is involved in the adherence of Porphyromonas gingivalis to human coronary artery endothelial cells. Infect Immun 2005;73:7267-73.
18. Li L, Messas E, Batista EL, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in heterozygous apolipoprotein E deficient murine model. Circulation 2002;105:861-7.
19. Brodala N, Merricks EP, Bellinger DA, Damrongsri D, Offenbacher S, Beck J, et al. Porphyromonas gingivalis bacteriemia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 2005;25:1446-51.
20. Prescription des antibiotiques en odontologie et stomatologie. Recommandations et argumentaire. Agence Française de Sé curité Sanitaire des Produits dela Santé; 2001. (www.afssaps.sante.fr).
21. French Health Products Safely Agency (Afssaps). Prescribing antibiotics in odontology and stomatology. Recommendations by the French Health Products Safety Agency. Fundam Clin Pharmacol 2003;17:725-9.
22. Durack DT. Prophylaxis of infective endocarditis. En: Mandell GL, Bennett JE, Dolin R, editors. Mandel I, Douglas, and Bennett principles and practice of infectious diseases, 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005. p. 1044-50.
23. Dajani AS, Taubert KA, Wilson W. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis. 1997;25:1448-58.
24. Tomás Carmona I, Diz Dios P, Limares Posse J, Cutumure Rial M, Caamano Duran F, Fernández Feijoo J, et al. Chemoprophylaxis of bacterial endocarditis recommended by general dental practitioners in Spain. Med Oral 2004;9:56-62.
25. Geerts SO, Nys M, De MP, Charpentier J, Albert A, Legrand V, et al. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol 2002;73:73-8.
26. Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 2006;33:401-7.
27. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Periodontal disease and coronary heart disease risk. JAMA 2000;284:1406-10.
28. Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M, Takashiba S, et al. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol 2003;74:1231-6.
29. Drucker DB, Gomes BP, Lilley JD. Role of anaerobic species in endodontic infection. Clin Infect Dis 1997;25:S220-1.
30. Loesche WJ, Grossman NS. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 2001;14:727-52.
31. Maestre JR, Giménez MJ, Bascones A. Odontopathogen susceptibility to amoxicillin/clavulanic acid and other common antibiotics used in odontology. 7Th European Congress of Chemotherapy and Infection. October 19-22. Florence. Italy; 2005. p. 209.
32. Brescó-Salinas M, Costa-Riu N, Berini-Aytés L, Gay-Escoda C. Antibiotic susceptibility of the bacteria causing odontogenic infections. Med Oral Patol Oral Cir Bucal 2006;11:E70-5.
33. Sixou JL, Magaud C, Jolivet-Gougeon A, Cormier M, Bonnaure-Mallet M. Microbiology of mandibular third molar pericoronitis: incidence of beta-lactamase producing bacteria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:655-9.
34. Heimdahl A, Von Konow L, Nord CE. Isolation of betalactamase producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Arch Oral Biol 1980;25:689-92.
35. Van Winkelhoff AJ, Herrera González D, Winkel EG, Dellemijn-Kippuw N, Vandenbroucke-Grauls CM, Sanz M. Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. A comparison between The Netherlands and Spain. J Clin Periodontol 2000;27:79-86.
36. Maestre Vera JR. Opciones terapéuticas en la infección de origen odontogénico. Med Oral Patol Oral Cir Bucal 2004;9 Suppl: S19-31.
37. Rodríguez-Avial I, Rodríguez-Avial C, Culebras E, Picazo JJ. Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid. Int J Antimicrob Agents 2003;21:536-41.
38. Tomás I, Alvarez M, Limeres J. In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain. Oral Microbiol Immunol. 2004;19:331-5.
39. Bascones A, Mansó F. Infecciones odontógenas en la cavidad bucal v región maxilofacial. Av Odontoestomatol 1994;10:5-26.
40. Poulet PP, Duffaut D, Barthet P, Brumpt I. Concentrations and in vivo antibacterial activity of spiramycin and metronidazole in patients with periodontitis treated with high-dose metronidazole and the spiramycin/ metronidazole combination. J Antimicrob Chemother 2005;55:347-51.
41. Isla A, Canut A, Rodríguez-Gascón A. Análisis farmacocinético/farmacodinámico (PK/PD) de la antibioterapia en odontoestomatología. Enferm Infecc Microbiol Clin 2005;23:116-21.
42. Offenbacher S, Katz V, Fertik G. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996;67 (10 Suppl):1103-13.
43. Overholser CD, Moreillon P, Glauser MP. Experimental bacterial endocarditis after dental extractions in rats with periodontitis. J Infect Dis 1987;155:107-12.
44. Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis 1996;22:276-86.
45. Lockhart PB. An analysis of bacteremias during dental extractions. A double-blind placebo-controlled study of chlorhexidine. Arch Intern med 1996;156:513-20.
46. Glauser MP, Bernard JP, Moreillon P, Francioli P. Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. J Infect Dis 1983;147:568-75.
47. Pogrel MA, Welsby PD. The dentist and prevention of infective endocarditis. Br Dent J 1975;139:12-6.
48. Roberts G, Holzel H. Intravenous antibiotic regimens and prophylaxis of odontogenic bacteraemia. Br Dent J 2002;193:525-7.
49. Martínez Lacasa J, Jiménez J, Ferrás VA et al. A double blind, placebo-controlled, randosmised, comparative phase III clinical trial of pharmacokinetically enhanced amoxicillin/clavulanate 2000/125, as prophylaxis or as treatment versus placebo for infectious and inflammatory morbidity after third mandibula removal. Program and Abstracts of the 43rd InterScience Conference on Antimicrobial Agents and Chemotherapy, Chicago 2003. American Society for Microbiology, Washington, DC.